Search

Binqi B Zeng

from San Diego, CA
Age ~59
Get Report
Related to:
Weiyue Zeng, 32
Connected to:
Boming Zeng, 52Echo ZengJianhao Zeng, 35Jinglan Zeng, 66Junling ZengNicole Zeng, 36Polly Zeng, 64Qinggang Zeng, 53Rachel ZengRan Zeng, 38

Binqi Zeng Phones & Addresses

  • 15058 Via Hondonada, San Diego, CA 92129 (858) 672-8980
  • 15058 Via Hondonada APT D, San Diego, CA 92129 (858) 672-8980
  • 13057 Evening Creek Dr S, San Diego, CA 92128
  • 13057 Evening Creek Dr S UNIT 52, San Diego, CA 92128
  • La Jolla, CA

Resumes

Resumes

Binqi Zeng Photo 1

Scientist Ii

View page
Location:
San Diego, CA
Industry:
Biotechnology
Work:
Targegen, Inc.
Scientist Ii
Binqi Zeng Photo 2

Binqi Zeng

View page

Publications

Us Patents

Bi-Aryl Meta-Pyrimidine Inhibitors Of Kinases

View page
US Patent:
7528143, May 5, 2009
Filed:
Oct 26, 2006
Appl. No.:
11/588638
Inventors:
Glenn Noronha - Oceanside CA, US
Chi Ching Mak - San Diego CA, US
Jianguo Cao - San Diego CA, US
Joel Renick - San Diego CA, US
Andrew McPherson - San Diego CA, US
Binqi Zeng - San Diego CA, US
Ved P. Pathak - San Diego CA, US
Daniel L. Lohse - San Diego CA, US
John D. Hood - San Diego CA, US
Richard M. Soll - San Diego CA, US
Assignee:
TargeGen, Inc. - San Diego CA
International Classification:
A01N 43/54
A61K 31/505
C07D 239/02
C07D 401/00
C07D 403/00
C07D 407/00
C07D 409/00
C07D 411/00
C07D 413/00
C07D 417/00
C07D 419/00
US Classification:
514275, 544323, 544324
Abstract:
The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.

Bi-Aryl Meta-Pyrimidine Inhibitors Of Kinases

View page
US Patent:
7825246, Nov 2, 2010
Filed:
Apr 26, 2007
Appl. No.:
11/796717
Inventors:
Glenn Noronha - Oceanside CA, US
Chi Ching Mak - San Diego CA, US
Jianguo Cao - San Diego CA, US
Joel Renick - San Diego CA, US
Andrew McPherson - San Diego CA, US
Binqi Zeng - San Diego CA, US
Ved P. Pathak - San Diego CA, US
Daniel L. Lohse - San Diego CA, US
John D. Hood - San Diego CA, US
Richard M. Soll - San Diego CA, US
Assignee:
TargeGen, Inc. - San Diego CA
International Classification:
C07D 239/02
US Classification:
544323
Abstract:
The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.

2-Amino—5-Substituted Pyrimidine Inhibitors

View page
US Patent:
8030487, Oct 4, 2011
Filed:
Jul 2, 2007
Appl. No.:
11/772572
Inventors:
Glenn Noronha - Fort Worth TX, US
Jianguo Cao - San Diego CA, US
Colleen Gritzen - Vista CA, US
Chi Ching Mak - San Diego CA, US
Andrew McPherson - San Diego CA, US
Ved P. Pathak - San Diego CA, US
Joel Renick - San Diego CA, US
Richard M. Soll - San Diego CA, US
Binqi Zeng - San Diego CA, US
Elena Dneprovskaia - San Diego CA, US
Assignee:
TargeGen, Inc. - San Diego CA
International Classification:
C07D 239/42
C07D 401/12
C07D 401/14
C07D 403/12
C07D 403/14
A61K 31/505
A61K 31/506
A61P 19/02
A61P 35/00
US Classification:
544320, 544330, 514272, 514275
Abstract:
Compounds having the general structure (A) are provided. The compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, Vegfr and various other specific receptor and non-receptor kinases.

Benzotriazine Inhibitors Of Kinases

View page
US Patent:
8481536, Jul 9, 2013
Filed:
Dec 28, 2010
Appl. No.:
12/980235
Inventors:
Xianchang Gong - La Jolla CA, US
Kathy Barrett - La Jolla CA, US
Jianguo Cao - San Diego CA, US
Colleen Gritzen - Vista CA, US
Glenn Noronha - Seattle WA, US
John D. Hood - San Diego CA, US
Chi Ching Mak - San Diego CA, US
Andrew McPherson - San Diego CA, US
Ved Prakash Pathak - San Diego CA, US
Joel Renick - San Diego CA, US
Richard M. Soll - San Diego CA, US
Ute Splittgerber - South San Francisco CA, US
Wolfgang Wrasidlo - La Jolla CA, US
Binqi Zeng - San Diego CA, US
Ningning Zhao - San Diego CA, US
Elena Dneprovskaia - San Diego CA, US
Assignee:
TargeGen, Inc. - Bridgewater NJ
International Classification:
A61K 31/53
A61P 35/00
C07D 401/12
C07D 401/14
C07D 403/04
C07D 403/12
C07D 403/14
C07D 413/12
C07D 413/14
C07D 417/12
C07D 417/14
US Classification:
514243, 544183
Abstract:
The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.

Bi-Aryl Meta-Pyrimidine Inhibitors Of Kinases

View page
US Patent:
8604042, Dec 10, 2013
Filed:
Aug 24, 2010
Appl. No.:
12/862517
Inventors:
Glenn Noronha - Seattle WA, US
Chi Ching Mak - San Diego CA, US
Jianguo Cao - San Diego CA, US
Joel Renick - San Diego CA, US
Andrew McPherson - San Diego CA, US
Binqi Zeng - San Diego CA, US
Ved P. Pathak - San Diego CA, US
Daniel L. Lohse - Silvis IL, US
John D. Hood - San Diego CA, US
Richard M. Soll - San Diego CA, US
Assignee:
TargeGen, Inc. - Bridgewater NJ
International Classification:
A01N 43/54
C07D 239/42
C07D 401/04
C07D 401/00
C07D 403/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00
C07D 417/00
C07D 419/00
US Classification:
514256, 544329
Abstract:
The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.

Pyrimidine Inhibitors Of Kinases

View page
US Patent:
20060247250, Nov 2, 2006
Filed:
Mar 15, 2006
Appl. No.:
11/377234
Inventors:
Jianguo Cao - San Diego CA, US
Richard Soll - San Diego CA, US
Glenn Noronha - Oceanside CA, US
Kathy Barrett - San Diego CA, US
Colleen Gritzen - Vista CA, US
John Hood - San Diego CA, US
Chi Mak - San Diego CA, US
Andrew McPherson - San Diego CA, US
Ved Pathak - San Diego CA, US
Joel Renick - San Diego CA, US
Ute Splittgerber - South San Francisco CA, US
Binqi Zeng - San Diego CA, US
Assignee:
TargeGen, Inc. - San Diego CA
International Classification:
A61K 31/506
C07D 403/14
C07D 403/02
US Classification:
514252140, 544329000, 544295000, 514275000
Abstract:
The invention provides pyrimidine compounds having formula A. The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, and various other specific receptor and non-receptor kinases.

Six Membered Heteroaromatic Inhibitors Targeting Resistant Kinase Mutations

View page
US Patent:
20070149508, Jun 28, 2007
Filed:
Oct 31, 2006
Appl. No.:
11/591076
Inventors:
Glenn Noronha - Oceanside CA, US
Jianguo Cao - San Diego CA, US
Binqi Zeng - San Diego CA, US
Chi Mak - San Diego CA, US
Andrew McPherson - San Diego CA, US
Joel Renick - San Diego CA, US
Ved Pathak - San Diego CA, US
Chun Chow - San Diego CA, US
Moorthy Palanki - Encinitas CA, US
Richard Soll - San Diego CA, US
Daniel Lohse - San Diego CA, US
John Hood - San Diego CA, US
Elena Dneprovskaia - San Diego CA, US
Assignee:
TargeGen, Inc. - San Diego CA
International Classification:
A61K 31/551
A61K 31/53
A61K 31/506
C07D 403/02
US Classification:
514218000, 514242000, 514252140, 514256000, 540575000, 544295000, 544333000, 544182000
Abstract:
A compound is provided, having the general structure (A): wherein A is an (un)substituted aryl or (un)substituted heteroaryl moiety, G is N, CH, or CR, R is an unsubstituted or substituted lower alkyl, Y is a hydrophobic linking moiety, and L is a substitutent as defined. The compound (A) can be used for treatment of various angiogenic and hematological-associated disorders, such as myeloproliferative disorder in patients who do not respond to kinase-inhibition therapy that comprises administering approved medications.

Thiazole Inhibitors Targeting Resistant Kinase Mutations

View page
US Patent:
20070161645, Jul 12, 2007
Filed:
Oct 31, 2006
Appl. No.:
11/591252
Inventors:
Glenn Noronha - Oceanside CA, US
Jianguo Cao - San Diego CA, US
Binqi Zeng - San Diego CA, US
Chi Mak - San Diego CA, US
Andrew McPherson - San Diego CA, US
Joel Renick - San Diego CA, US
Ved Pathak - San Diego CA, US
Chun Chow - San Diego CA, US
Moorthy Palanki - Encinitas CA, US
Richard Soll - San Diego CA, US
Daniel Lohse - San Diego CA, US
John Hood - San Diego CA, US
Elena Dneprovskaia - San Diego CA, US
Assignee:
TargeGen, Inc. - San Diego CA
International Classification:
A61K 31/506
A61K 31/496
A61K 31/454
A61K 31/427
A61K 31/428
C07D 417/14
US Classification:
514252190, 514254020, 514326000, 514365000, 544295000, 544369000, 546208000, 548190000
Abstract:
A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophbic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.
Control profile
Binqi B Zeng from San Diego, CA, age ~59 Get Report